Katinger H - Search Results

1

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Binley JM, Wrin T, Korber B, Zwick MB, Wang M, Chappey C, Stiegler G, Kunert R, Zolla-Pazner S, Katinger H, Petropoulos CJ, Burton DR. Binley JM, et al. Among authors: katinger h. J Virol. 2004 Dec;78(23):13232-52. doi: 10.1128/JVI.78.23.13232-13252.2004. J Virol. 2004. PMID: 15542675 Free PMC article.

2

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

Wolbank S, Kunert R, Stiegler G, Katinger H. Wolbank S, et al. Among authors: katinger h. J Virol. 2003 Apr;77(7):4095-103. doi: 10.1128/jvi.77.7.4095-4103.2003. J Virol. 2003. PMID: 12634368 Free PMC article.

3

The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.

Zwick MB, Komori HK, Stanfield RL, Church S, Wang M, Parren PW, Kunert R, Katinger H, Wilson IA, Burton DR. Zwick MB, et al. Among authors: katinger h. J Virol. 2004 Mar;78(6):3155-61. doi: 10.1128/jvi.78.6.3155-3161.2004. J Virol. 2004. PMID: 14990736 Free PMC article.

4

Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10.

Mehandru S, Wrin T, Galovich J, Stiegler G, Vcelar B, Hurley A, Hogan C, Vasan S, Katinger H, Petropoulos CJ, Markowitz M. Mehandru S, et al. Among authors: katinger h. J Virol. 2004 Dec;78(24):14039-42. doi: 10.1128/JVI.78.24.14039-14042.2004. J Virol. 2004. PMID: 15564511 Free PMC article.

5

Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.

Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR. Zwick MB, et al. Among authors: katinger h. J Virol. 2005 Jan;79(2):1252-61. doi: 10.1128/JVI.79.2.1252-1261.2005. J Virol. 2005. PMID: 15613352 Free PMC article.

6

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.

Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, Burton DR, Wilson IA. Cardoso RM, et al. Among authors: katinger h. Immunity. 2005 Feb;22(2):163-73. doi: 10.1016/j.immuni.2004.12.011. Immunity. 2005. PMID: 15723805 Free article.

7

Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope.

Arnold GF, Velasco PK, Holmes AK, Wrin T, Geisler SC, Phung P, Tian Y, Resnick DA, Ma X, Mariano TM, Petropoulos CJ, Taylor JW, Katinger H, Arnold E. Arnold GF, et al. Among authors: katinger h. J Virol. 2009 May;83(10):5087-100. doi: 10.1128/JVI.00184-09. Epub 2009 Mar 11. J Virol. 2009. PMID: 19279101 Free PMC article.

8

Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B.

Kitabwalla M, Ferrantelli F, Wang T, Chalmers A, Katinger H, Stiegler G, Cavacini LA, Chou TC, Ruprecht RM. Kitabwalla M, et al. Among authors: katinger h. AIDS Res Hum Retroviruses. 2003 Feb;19(2):125-31. doi: 10.1089/088922203762688630. AIDS Res Hum Retroviruses. 2003. PMID: 12639248

9

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.

Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA. Calarese DA, et al. Among authors: katinger h. Science. 2003 Jun 27;300(5628):2065-71. doi: 10.1126/science.1083182. Science. 2003. PMID: 12829775

10

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, Poignard P, Burton DR, Letvin NL. Mascola JR, et al. Among authors: katinger h. J Virol. 2003 Oct;77(19):10348-56. doi: 10.1128/jvi.77.19.10348-10356.2003. J Virol. 2003. PMID: 12970419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters